Dipna Pharmachem IPO vs Shantidoot Infra IPO

Comparison between Dipna Pharmachem IPO and Shantidoot Infra IPO.

IPO Details

Dipna Pharmachem IPO is a SME Fixed Price IPO proposed to list at BSE SME while Shantidoot Infra IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Dipna Pharmachem IPO is up to ₹14.43 Cr whereas the issue size of the Shantidoot Infra IPO is up to ₹3.81 Cr. The final issue price of Dipna Pharmachem IPO is ₹38.00 per share and of Shantidoot Infra IPO is ₹81.00 per share.

 Dipna Pharmachem IPOShantidoot Infra IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)₹38.00 per share₹81.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size3000 shares1600 shares
Fresh Issue Size37,98,000 shares2,22,400 shares
Fresh Issue Size (Amount)up to ₹14.43 Crup to ₹1.80 Cr
OFS Issue Size0 shares2,48,000 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹2.01 Cr
Issue Size Total37,98,000 shares4,70,400 shares
Issue Size Total (Amount)up to ₹14.43 Crup to ₹3.81 Cr

IPO Timetable

Dipna Pharmachem IPO opens on Aug 25, 2022, while Shantidoot Infra IPO opens on Sep 06, 2022. The closing date of Dipna Pharmachem IPO and Shantidoot Infra IPO is Aug 30, 2022, and Sep 09, 2022, respectively.

Financials & KPIs

Dipna Pharmachem IPO P/E ratio is 39, as compared to Shantidoot Infra IPO P/E ratio of 10.37.

 Dipna Pharmachem IPOShantidoot Infra IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 202231 Mar 202131 Mar 2020
Assets36.2324.7918.44
Total Income72.7731.0230.55
Profit After Tax1.170.020.06
NET Worth1.740.570.55
Reserves and Surplus1.700.540.51
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Mar 202231 Mar 202131 Mar 2020
Assets3.531.860.66
Total Income7.624.162.19
Profit After Tax1.400.090.03
NET Worth1.570.160.08
Reserves and Surplus1.520.110.03
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)10099.60
Promoter Shareholding (Post-Issue)66.5672.07
P/E Ratio3910.37
Market Cap₹45.49 Cr.₹14.56 Cr.
ROE162
ROCE93
Debt/Equity0.42
EPS₹333.40₹9.06
RoNW67.1289.57

Shares Offered

In the Dipna Pharmachem IPO Retail Individual Investors (RII) are offered 18,99,000 shares while in Shantidoot Infra IPO retail investors are offered 18,99,000 shares. Qualified Institutional Buyers (QIB) are offered in Dipna Pharmachem IPO and in Shantidoot Infra IPO.

 Dipna Pharmachem IPOShantidoot Infra IPO
Anchor Investor Reservation
Market Maker Reservation2,04,000 shares25,600 shares
QIB
NII18,99,000 shares2,35,200 shares
RII18,99,000 shares2,35,200 shares
Employee
Others
Total37,98,000 shares4,70,400 shares

Bids Received (Subscription)

Dipna Pharmachem IPO subscribed 2.77x in total, whereas Shantidoot Infra IPO subscribed 2.85x.

Compare with others

Compare: